Healthcare & LifesciencesView All
Current Investments
-
KIMS Hospitals
Founded in 2000 by Dr. Bhaskar Rao Bollineni, Krishna Institute of Medical Sciences (“KIMS”) is the amongst the largest multi-specialty hospital chain based out of Andhra Pradesh, Telangana and Maharashtra with focus on providing tertiary and quaternary care at affordable cost. KIMS has a footprint of 13 hospitals (4,000+ beds) across Tier 1 and Tier 2/3 cities with a strong payor and specialty mix. It offers comprehensive range of healthcare services across 25 specialties and super specialties, including cardiac sciences, oncology, neurosciences, gastric sciences, orthopaedics, organ transplantation, renal sciences and mother & child care. It has been growth focused using the right balance of brownfield and greenfield expansions while maintaining industry leading return metrics.
-
Corona Remedies
Founded in 2004 by Dr. Kirti bhai Mehta and his two sons, Nirav and Ankur Mehta, CORONA is among the fastest growing companies in the domestic formulations sector in India. Its product range includes formulations in therapeutic segments like gynaecology, cardio diabetic, nutraceuticals, anti-infective, orthopaedic and paediatrics. CORONA has scaled up rapidly due to its experienced management team, diversified product range, focus on affordable yet high-quality formulations, robust distribution network and an experienced field force of 1,900+ medical representatives.
-
Eris Lifesciences
Eris Lifesciences is one of the leading mid-sized domestic pharmaceutical companies in India. The Company has established itself as a credible top 40 player in the domestic formulations industry. Eris Lifesciences has a sharp focus on the chronic and lifestyle diseases segment.
-
Intas Pharmaceuticals
Intas is one of the fastest growing domestic pharmaceutical companies in India and is amongst the largest companies in the industry. The Company has a diversified product portfolio focused on chronic segments. Intas has also built up a sizable export business focused on the regulated pharmaceutical markets.
-
Mankind Pharmaceuticals
Mankind Pharmaceuticals is the fourth largest domestic pharmaceutical company in India and is amongst the fastest growing domestic pharmaceutical companies. The Company has the largest distribution network in the country.
Select Exited Investments
-
Curatio Healthcare
Curatio Healthcare is one of India’s fastest growing pharmaceutical companies. The company is focused on the dermatology and pediatric segments, which are among the most attractive therapy areas within the pharmaceutical industry.
-
Ipca Laboratories
Ipca Laboratories (“IPCA”) is an integrated pharmaceuticals player producing both domestic formulations and active pharmaceutical ingredients. The Company also serves the regulated and unregulated export markets. In addition, IPCA is also an established player in the anti-malarial institutional market.
-
Torrent Pharma
Torrent Pharmaceuticals is a large pharmaceuticals player with a presence in both the domestic and export formulations market. The Company is amongst the top 15 players in India, with a chronic focused basket of formulation products. Torrent Pharmaceuticals also exports products to key markets including the U.S., Brazil and Europe.
-
Cadila Healthcare
Cadila is the one of the largest domestic pharmaceutical companies with a focus on the formulations market. The Company is strong in the cardiovascular, female healthcare and gastrointestinal therapeutic areas. Cadila has also built a strong position in regulated markets such as the U.S. and France and in emerging markets such as Brazil, South Africa and Russia.
-
GVK Biosciences
Founded in 2001, GVK BIO is one of Asia’s leading providers of integrated contract research and manufacturing services. The Company provides small and large molecule discovery services, custom chemical synthesis manufacturing and informatics services to large global pharmaceutical, biotechnology and agrochemical companies.